Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Thoracic 1NET 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Neuroendocrine Tumors 102Carcinoid Tumor 22Neoplasms 16Neoplasm Metastasis 10Gastro-enteropancreatic neuroendocrine tumor 10Carcinoma, Neuroendocrine 9Adenoma, Islet Cell 9Pancreatic Neoplasms 7Carcinoma 7Pheochromocytoma 6Paraganglioma 6Neuroblastoma 6Colorectal Neoplasms 6Carcinoma, Islet Cell 6Somatostatinoma 5Gastrointestinal Neoplasms 5Vipoma 4Small Cell Lung Carcinoma 4Serotonin Syndrome 4Neuroectodermal Tumors, Primitive 4Melanoma 4Medulloblastoma 4Lung Neoplasms 4Intestinal Neoplasms 4Gastrinoma 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma 4Prostatic Neoplasms 3Neuroectodermal Tumors 3Neoplasms, Nerve Tissue 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Genital Diseases, Male × NET × Clear all
NCT00753415 2015-03-17

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Merck Sharp & Dohme LLC

Phase 1 Completed
37 enrolled 10 charts
BreastDermatologicEndocrineGastrointestinalGenitourinaryNETThoracic

Adenocarcinoma, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Breast Diseases, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Genital Diseases, Male, Intestinal Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Prostatic Diseases, Prostatic Neoplasms, Skin Diseases, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Colorectal Neoplasms, Neuroectodermal Tumors, Nevi and Melanomas, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡